Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025
By R. Burge, B. Dawson-Hughes, Daniel H. Solomon, John B. Wong, Alison B King, A. Tosteson. Journal of Bone and Mineral Research, 2007
3,933 citations recorded by the source corpus.
Subfields: Orthopedics and Sports Medicine, Pediatrics, Perinatology and Child Health, Surgery
View Paper: https://www.semanticscholar.org/paper/818acca65376fd34948e7ff1c15bb6d3c22cf10b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Orthopedics and Sports Medicine
- Chris Cooper
- J. Kanis
- Eugene V. McCloskey
- Nicholas C. Harvey
- William D. Leslie
- D. Hans
- M. Krieg
- Elaine Dennison
In Pediatrics, Perinatology and Child Health
In Surgery
- Chris Cooper
- Eugene V. McCloskey
- J. Kanis
- Nicholas C. Harvey
- William D. Leslie
- D. Hans
- M. Krieg
- Andrew L. Goertzen
Citations in the corpus
- Osteoporosis: impact on health and economics (2010, background): “The cost of fragility fractures for 2005 in the USA was an estimated d19 billion”
- Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: The manitoba study (2011, background): “In the United States, osteoporosis affects as many as 4 to 6 million postmenopausal women,((7)) with 2 million fractures occurring annually.((8)) Up to 10% of women in their fifties have already experienced an osteoporotic fracture.”
- Trabecular Bone Score: A Noninvasive Analytical Method Based Upon the DXA Image (2014, background): “In the United States, osteoporosis affects as many as 10 million individuals over the age of 50 years,((7)) with 2 million fractures occurring annually.((8)) The chance that awoman>50 years of agewill suffer an osteoporotic fracture in her lifetime is 40% in theUnited States.”
- The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro. (2010, background): “Annual direct costs due to osteoporosis-related fracture in the United States are estimated in the range of US$20 billion [1] and its disease burden in Europe is estimated to be greater than that attributed to any cancer save lung [2].”
- The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group (2014, background): “associated fractures [22], and proximal humerus fractures are among the four “major osteoporotic fractures” together with hip, spine, and distal forearm fractures in FRAX [15].”
- ACR appropriateness criteria acute hip pain-suspected fracture. (2014, background): “The economic impact of proximal femoral fracture has been estimated at $40,000 per patient [4-7].”
- Incidence and Mortality of Hip Fractures in the United States (2009, neutral): “Age, y 65-74 5558 (24) 5472 (20) 14 838 (18) 11 135 (13)”
- Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards (2011, background): “s-OC Serum osteocalcin Hydroxyapatite-binding protein exclusively synthesised by osteoblasts and odontoblasts Automated Specificity: specific marker of osteoblast function Manual Subject to rapid degradation in serum leads to heterogeneity of OC fragments: usually measured as intact [1–49] or N-mid ”